Skip to the page

Data / Form D filings / Reprogram Biosciences, Inc.

Reprogram Biosciences, Inc.: Form D filings

Reprogram Biosciences, Inc., a biotechnology company in San Carlos, CA, filed 2 Form D notices with the SEC between 2025 and 2026. The latest, on May 26, 2026, reports $5 million sold of a $5 million offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1030 BRITTAN AVE, San Carlos, CA, 94070
Phone
(929) 245-6645
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2025
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2069701

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 26, 2026New notice$5,000,000$5,000,0002Mar 16, 2026sec.gov
May 23, 2025New notice$1,000,000$1,000,0003May 9, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Rustam EsanovExecutive Officer, Director

Other biotechnology companies in California that filed recently

Every Form D from the week of May 25, 2026 · All recent filings in California · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Reprogram Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.